Blueprint Medicines

-$2.02 (-2.34%) Today
$0.00 (0.00%) As of 11:04 PM UTC after-hours

Why Robinhood?

You can buy or sell BPMC and other stocks, options, and ETFs commission-free!

About BPMC

Blueprint Medicines Corporation Common Stock, also called Blueprint Medicines, is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy.

CEO
Jeffrey W. Albers
Employees
429
Headquarters
Cambridge, Massachusetts
Founded
2008

BPMC Key Statistics

Market Cap
4.92B
Price-Earnings Ratio
15.30
Dividend Yield
—
Average Volume
812.34K
High Today
$86.84
Low Today
$83.78
Open Price
$86.37
Volume
329.10K
52 Week High
$125.61
52 Week Low
$66.20

BPMC Earnings

-$2.28
$2.20
$6.68
$11.16
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure